Skip to main content
SpringerLink
Log in

Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

When rats which had been pretreated with a high dose of diphenylhydantoin (80 mg/kg) for 5 days were given a single intravenous dose of phenobarbital (30 mg/kg):

  1. (a)

    There was no increase in the rate at which phenobarbital (PB) disappeared from the plasma or the tissues of pretreated rats.

  2. (b)

    The percentages of phenobarbital and p-hydroxyphenobarbital (free and conjugated) excreted in the urine were similar in both treated and control animals. However, the percentage of conjugated p-hydroxyphenobarbital excreted, was almost twice that of the control group.

  3. (c)

    Pretreatment with diphenylhydantoin (DPH) markedly increased bile flow rates. Therefore these rats excreted more PB than their controls. The biliary excretion of hydroxylated metabolites of PB (free and conjugated), was similar to that found in urine. Hydroxylation was not increased although, there was a significant elevation in the percentage of conjugated metabolite excreted.

In a study to establish whether the main metabolites of diphenylhydantoin interfered with the metabolism of phenobarbital the following results were obtained:

  1. (a)

    Intravenous administration of DPH together with PB caused a two-fold increase in the half-life of phenobarbital elimination.

  2. (b)

    Intravenous administration of PB, to bile duct cannulated rats which had been pretreated for 5 days with DPH, caused a significant reduction in the excretion of hydroxylated phenobarbital in comparison with their control group. However, all the excreted DPH was present in the conjugated form.

  3. (c)

    The DPH pretreated rats had significantly lower cytochrome P-450 and mono-oxygenase activities in their hepatic microsomes than the pretreated controls, and higher UDP-glucuronyltransferase activity with DPH itself as the substrate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Livingston, S. (1976) Drug therapy for epilepsy p. 16, Charles C. Thomas, Springfield, Ill.

    Google Scholar 

  2. Kutt H. (1975) Interactions of antiepileptic drugs. Epilepsia, 16, 393–402.

    Article  CAS  PubMed  Google Scholar 

  3. Morselli P.L. (1973) Anticonvulsant drug interactions In: Drug Interaction, (Morselli P.L., Cohen S.N. and Garattini S., Eds) pp. 52–65, Raven Press, New York.

    Google Scholar 

  4. Butler T.C. (1956) The metabolic hydroxylation of phenobarbital. J. Pharmacol. Exp. Ther., 11, 326–336.

    Google Scholar 

  5. Glazko A.J. (1973) Diphenylhydantoin metabolism, a prospective review. Drug Met. Disp., 1. 711–714.

    CAS  Google Scholar 

  6. Butler T.C, Dudley K.H., Johnson D. and Robert S.B. (1976) Studies of the metabolism of 5,5-diphenylhydantoin relating principally to the stereoselectivity of the hydroxylation in man and dog. J. Pharmacol. Exp. Ther., 199. 82–91.

    CAS  PubMed  Google Scholar 

  7. Conney A.H. (1967) Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev., 19, 317–385.

    CAS  PubMed  Google Scholar 

  8. Andreasen P.B., Lyngbye L. and Trolle E. (1973) Abnormalities in liver function tests during long-term diphenylhydantoin therapy in epileptic patients. Acta Med. Scand., 194. 261–264.

    CAS  PubMed  Google Scholar 

  9. Eling T.E., Harbison R.D., Becker B.A. and Fouts J.R. (1970) Kinetic changes in microsomal drug metabolism with age and diphenylhydantoin treatment. Europ. J. Pharmacol., 1, 101–108.

    Article  Google Scholar 

  10. Petruch F., Schuppel R.V.A. and Steinhilber G. (1974) Effect of diphenylhydantoin on hepatic drug hydroxylation. Europ. J. Clin. Pharmacol., 7, 281–285.

    Article  CAS  Google Scholar 

  11. Werk E.E., MacGee J.R.J, and Sholiton L.J. (1964) Effect of diphenylhydantoin on Cortisol metabolism in man. J. Clin. Invest., 43, 1824–1835.

    Article  CAS  PubMed  Google Scholar 

  12. Harbison R.D., Eling T.E. and Becker B.A. (1969) Effects of diphenylhydantoin on neonatal rat drugmetabolizing enzymes. Fed. Proa, 28, 676.

    Google Scholar 

  13. Kristensen M., Hansen J.H. and Skovsted L. (1969) The influence of phenobarbital on the half-life of diphenylhydantoin in man. Acta Med. Scand., 185, 347–350

    CAS  PubMed  Google Scholar 

  14. Morselli P.L., Rizzo M. and Garattini S. (1971) Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients. Ann. N.Y. Acad. Sci., 179. 88–107.

    Article  CAS  PubMed  Google Scholar 

  15. Rizzo M., Morselli P.L. and Garattini S. (1972). Further observations on the interactions between phenobarbital and diphenylhydantoin during chronic treatment in the rat Biochem. Pharmacol., 21, 449–454.

    CAS  Google Scholar 

  16. Lockard J.S., Levy R.H., Uhlir V. and Farquhar J.A. (1976) Interaction of phenytoin and phenobarbital in terms of order and temporal spacing of administration in monkeys. Epilepsia, 17, 481–485.

    Article  CAS  PubMed  Google Scholar 

  17. Kemp J.W., Tannhauser M. and Swinyard E.A. (1971) Effect of diphenylhydantoin on hexobarbital sleep time in mice and rats. Arch. Int. Pharmacodyn., 193. 37–47.

    CAS  PubMed  Google Scholar 

  18. Soda D.M. and Levy G. (1975) Inhibition of drug metabolism by hydroxylated metabolites. J. Pharm. Sci., 64, 1928–1931

    Article  CAS  PubMed  Google Scholar 

  19. Conard G.J., Haouik C.O. and Finger K.F. (1971) Binding of 5,5-diphenylhydantoin and its major metabolite to human and rat plasma proteins. J. Pharm. Sci., 60. 1642–1646

    Article  CAS  PubMed  Google Scholar 

  20. Ashley J.J. and Levy G. (1972) Inhibition of diphenylhydantoin elimination by its major metabolite. Res. Commun. Chem. Pathol. Pharmacol., 4, 297

    CAS  PubMed  Google Scholar 

  21. Stavchansky S.A., Lubawy W.C. and Lostenbauder H.B. (1974) Increase of hexobarbital sleeping and inhibition of drug metabolism by the major metabolite of diphenylhydantoin. Life Sci., 14, 1535–1539

    Article  CAS  PubMed  Google Scholar 

  22. Lubawy W.C, Kostenbauder H.B. and Stavehansky S.A. (1974) Gross inhibition of drug metabolism by drug metabolites. Increase of zoxazolamine paralysis time by the major metabolite of diphenylhydantoin. Res. Commun. Chem. Path. Pharmacol., 8, 75–82

    CAS  Google Scholar 

  23. Von Bahr C. (1970) Binding to cytochrome P-450 metabolism of desmethylimipramine and metabolites in rat liver imcrosomes. Acta Pharmacol. Toxicol., 28, 13

    Google Scholar 

  24. Hogeboom G.H. (1955) Fractionation of cell components of animal tissues. In: Methods in Enzymol., 1, 16, Kaplan, Ed.

    Article  CAS  Google Scholar 

  25. Lowry O.H., Rosebrough N.J., Faar A.L. and Randall R.J. (1951) Protein measurement with the Folin reagent J. Biol. Chem., 193, 265–275

    CAS  PubMed  Google Scholar 

  26. Omura T. and Sato N. (1962) The carbon monoxide binding pigment of liver microsomes. II. Solubilization, purification and properties. J. Biol. Chem., 239, 2379–2385

    Google Scholar 

  27. Williams C.H. and Kamin H. (1962) Microsomal triphosphopyridine nucleotide-cytochrome C reductase of liver. J. Biol. Chem. 237, 587–595

    CAS  PubMed  Google Scholar 

  28. Yang C.S. and Strickhart F.S. (1974) Inhibition of hepatic mixed-function oxidase by propyl gallate. Biochem. Pharmacol., 23, 2129–2138

    Article  Google Scholar 

  29. Netter K.J. and Seidel G. (1964) Kinetic studies of oxidative demethylation of p-nitroanisol by rat liver microsomes. J. Pharmacol. Exp. Ther., 146, 61–65

    CAS  PubMed  Google Scholar 

  30. Mulder G.J. and Van Doom A.B.D. (1975) A rapid NAD-linked assay for microsomal uridine diphosphate glucuronyl-transferase of rat liver and some observations on substrate specificity of the enzyme. Biochem. J., 151, 131

    CAS  PubMed  Google Scholar 

  31. Sarhan F., Ziegler J.M., Nicolas A. and Siest G. (1980) Rapid method for simultaneous determination of phenobarbital and diphenylhydantoin and their main hydroxylated metabolites by nitrogen selective GLC J. Chromatogr. 183, 505

    Article  CAS  PubMed  Google Scholar 

  32. Khodjet El Khil R., Batt A.M., Siest G., Thirion P. and Weber M. (1975) Methode de dosage de la diphénylhydantoine et du phénobarbital par Chromatographie en phase gazeuse. Path. Biol., 23, 409–416

    Google Scholar 

  33. Sarhan F., Engasser J.M., Letourneur P. and Falcoz C. (1980) Pharmacokinetic models for phenobarbital in the rat In: Drug Measurement and Drug Effect in Laboratory Health Science G. Siest and D. Young Eds. Karger Basel, pp. 128–134

    Google Scholar 

  34. Nottari R. (1975) Biopharmaceutics and pharmacokinetics; An Introduction Marcel Dekker, New York, pp. 16–30

    Google Scholar 

  35. Croft J.E., Caldwell J. and Smith R.L. (1978) Phenobarbitone disposition in relation to tolerance. Biochem. Soc, Transact, 6, 146–248

    Google Scholar 

  36. Klaassen C.D. (1971) Biliary excretion of barbiturates. Brit. J. Pharmacol., 43, 161–166

    CAS  Google Scholar 

  37. Klaassen C.D. (1971) Studies on the increased biliary flow produced by phenobarbital in rats. Pharmacol. Exp. Ther., 176, 743–751

    CAS  Google Scholar 

  38. Paugartner G., Harak W. and Probst P. (1971) Effect of phenobarbital on bile flow and bile salt excretion in the rat. Naunyn-Schmiedeberg’s Archiv. Pharmakol., 270, 98–101

    Google Scholar 

  39. Capron J.P. and Erlinger S. (1975) Barbiturates and biliary function. Digestion, 12, 43–56

    Article  CAS  PubMed  Google Scholar 

  40. El Hawary A.M. and Plaa G.L. (1978) Role of the enterohepatic circulation in the elimination of Phenytoin in the rat. Drug. Met. Dispos., 6, 59–69

    Google Scholar 

  41. Glazko A.J. and Chang T. (1972) Absorption, distribution and excretion of diphenylhydantoin. In: Antiepileptic Drugs, (Woodbury D.M., Penry J.K. and Schmidt R.P., Eds) Raven Press, New York, pp. 127–136

    Google Scholar 

  42. Inaba T., Umeda T., Endreyi L., Mahon W.A. and Kalow W. (1978) Uptake and metabolism of diphenylhydantoin in the isolated perfused rat liver. Biochem. Pharmacol., 27, 1151–1158

    Article  CAS  PubMed  Google Scholar 

  43. Levy G. and Ashley J.J. (1973) Effect of an inhibitor of glucuronide formation on elimination kinetics of diphenylhydantoin in rats. J. Pharm. Sci., 62, 161–162

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Biochimie Pharmacologique E.R.A., C.N.R.S. No 698. 7, rue Albert Lebrun, 54001, NANCY CEDEX, France

    Sarhan F, Batt A. M., Magdalou J. & Siest G.

  2. Laboratoire des Sciences du Génie Chimique CNRS, ENS1C 1, rue Grandville, 54042, NANCY CEDEX, France

    Engasser J. M.

Authors
  1. Sarhan F
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Engasser J. M.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Batt A. M.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Magdalou J.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Siest G.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarhan, F., Engasser, J.M., Batt, A.M. et al. Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite. European Journal of Drug Metabolism and Pharmacokinetics 6, 99–108 (1981). https://doi.org/10.1007/BF03189475

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189475

Key words

Search

Navigation